Northern Trust Corp Otonomy, Inc. Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$1.72 - $2.51 $1,365 - $1,992
-794 Reduced 0.71%
110,902 $231,000
Q1 2022

May 13, 2022
SELL
$1.72 - $2.47 $10,072 - $14,464
-5,856 Reduced 4.98%
111,696 $268,000
Q4 2021

Feb 08, 2022
SELL
$1.69 - $2.31 $12,051 - $16,472
-7,131 Reduced 5.72%
117,552 $245,000
Q3 2021

Nov 15, 2021
SELL
$1.22 - $2.2 $6,196 - $11,173
-5,079 Reduced 3.91%
124,683 $239,000
Q2 2021

Aug 13, 2021
BUY
$2.06 - $2.67 $16,791 - $21,763
8,151 Added 6.7%
129,762 $290,000
Q1 2021

May 12, 2021
SELL
$2.49 - $6.23 $7,385 - $18,478
-2,966 Reduced 2.38%
121,611 $310,000
Q4 2020

Feb 11, 2021
SELL
$3.48 - $6.47 $26,374 - $49,036
-7,579 Reduced 5.73%
124,577 $807,000
Q3 2020

Nov 16, 2020
BUY
$3.16 - $4.36 $147,341 - $203,293
46,627 Added 54.52%
132,156 $536,000
Q2 2020

Aug 14, 2020
SELL
$1.87 - $3.84 $3,928 - $8,067
-2,101 Reduced 2.4%
85,529 $310,000
Q1 2020

May 14, 2020
SELL
$1.58 - $4.06 $184 - $475
-117 Reduced 0.13%
87,630 $172,000
Q4 2019

Feb 14, 2020
SELL
$2.13 - $3.83 $1,388 - $2,497
-652 Reduced 0.74%
87,747 $336,000
Q3 2019

Nov 13, 2019
SELL
$2.12 - $2.86 $1,615 - $2,179
-762 Reduced 0.85%
88,399 $212,000
Q2 2019

Aug 13, 2019
SELL
$2.35 - $3.09 $9 - $12
-4 Reduced -0.0%
89,161 $245,000
Q1 2019

May 13, 2019
SELL
$1.8 - $2.97 $293 - $484
-163 Reduced 0.18%
89,165 $235,000
Q4 2018

Feb 12, 2019
SELL
$1.51 - $2.93 $4,030 - $7,820
-2,669 Reduced 2.9%
89,328 $165,000
Q3 2018

Nov 14, 2018
SELL
$2.6 - $3.95 $1,097 - $1,666
-422 Reduced 0.46%
91,997 $253,000
Q2 2018

Sep 18, 2018
SELL
$3.7 - $4.75 $7,000 - $8,987
-1,892 Reduced 2.01%
92,419 $355,000
Q2 2018

Aug 14, 2018
SELL
$3.7 - $4.75 $830,860 - $1.07 Million
-224,557 Reduced 70.42%
94,311 $363,000
Q1 2018

May 09, 2018
SELL
$4.05 - $6.1 $959 - $1,445
-237 Reduced 0.07%
318,868 $1.34 Million
Q4 2017

Feb 14, 2018
SELL
$2.8 - $5.55 $50,246 - $99,594
-17,945 Reduced 5.32%
319,105 $1.77 Million
Q3 2017

Nov 13, 2017
BUY
$3.2 - $20.8 $1.08 Million - $7.01 Million
337,050
337,050 $1.1 Million

About OTONOMY, INC.

OTIC Quotes by TradingView
  • Ticker OTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,990,400
  • Description
  • Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...
More about OTIC
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email